J. Cobaleda

824 citations

20 papers · 615 indexed · h-index 14

Impact in

Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
Biological Psychiatry top 10%
- Tryptophan and brain disorders

Papers in ⓘ

Pharmacology 10
- Pharmacogenetics and Drug Metabolism 9
- Plant-based Medicinal Research 2
Ophthalmology 5
- Drug-Induced Ocular Toxicity 5

Co-authors: Adrián LLerena (19 shared papers)J. Benítez (7 shared papers)Carmen Martínez (3 shared papers)Julio Benítez (4 shared papers)Gunnar Edman (1 shared paper)Leif Bertilsson (1 shared paper)Daisy Schalling (1 shared paper)J. Benítez (1 shared paper)
Journals: Clinical Pharmacology & Therapeutics (3 papers)The Pharmacogenomics Journal (2 papers)European Journal of Clinical Pharmacology (2 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Anesthesiology (1 paper)
Partner nations: Spain United States Sweden

In The Last Decade

J. Cobaleda

20 papers receiving 590 citations

Peers

Countries citing papers authored by J. Cobaleda

Since Specialization

Citations

This map shows the geographic impact of J. Cobaleda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Cobaleda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Cobaleda more than expected).

Fields of papers citing papers by J. Cobaleda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Cobaleda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Cobaleda. The network helps show where J. Cobaleda may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Cobaleda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Cobaleda Line = papers co-authored together J. Cobaleda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Relationship between personality and debrisoquine hydroxylation capacity Acta Psychiatrica Scandinavica ·Adrián LLerena, Gunnar Edman, J. Cobaleda, J. Benítez, Daisy Schalling, Leif Bertilsson	1993	124
2	Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype European Journal of Drug Metabolism and Pharmacokinetics ·Adrián LLerena, J. Cobaleda, Carmen Martínez, J. Benítez	1996	70
3	Debrisoquine oxidation phenotype during neuroleptic monotherapy European Journal of Clinical Pharmacology ·Edoardo Spina, Carmelo Martines, Achille P. Caputi, J. Cobaleda, B. Pi�as, Juan Antonio Carrillo, J. Benítez	1991	58
4	Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agents Clinical Pharmacology & Therapeutics ·Adrián LLerena, Angustias G. Herráiz, J. Cobaleda, Inger Johansson, Marja‐Liisa Dahl	1993	50
5	Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distributions analysis Clinical Pharmacology & Therapeutics ·Thomas K. Henthorn, Julio Benítez, Michael J. Avram, Carmen Martínez, Adrián LLerena, J. Cobaleda, Tom C. Krejcie, Robert D. Gibbons	1989	43
6	Debrisoquin oxidation polymorphism in a Spanish population Clinical Pharmacology & Therapeutics ·Julio Benítez, Adrián LLerena, J. Cobaleda	1988	41
7	VEGF-related polymorphisms identified by GWAS and risk for major depression Translational Psychiatry ·Ting Xie, Maria G. Stathopoulou, Fernando de Andrés, Gérard Siest, Helena Murray, Carmen Martín, J. Cobaleda, A. Delgado, John Lamont, E Peñas-LIedó, Adrián LLerena, Sophie Visvikis‐Siest	2017	33
8	Oxidative polymorphism of debrisoquine in Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry ·J. Benítez, José M. Ladero, F J Jiménez-Jiménez, Carmen Martínez, A M Puerto, María José López de Valdivielso, Adrián LLerena, J. Cobaleda, Jacob M. Muñoz	1990	31
9	Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5‐HTTLPR‐S) and the CYP2C93* allele Fundamental and Clinical Pharmacology ·Pedro Dorado, Eva Peñas‐Lledó, Antonio Poyato González, Macarena C. Cáceres, J. Cobaleda, Adrián LLerena	2007	29
10	Interethnic differences in the relevance of CYP2C9 genotype and environmental factors for diclofenac metabolism in Hispanics from Cuba and Spain The Pharmacogenomics Journal ·Adrián LLerena, Miguel Ángel Álvarez González, Pedro Dorado, Idilio González, Eva Peñas‐Lledó, B Pérez, J. Cobaleda, Luis R. Calzadilla	2013	29
11	High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studies The Pharmacogenomics Journal ·M.E.G. Naranjo, Fernando de Andrés, A. Delgado, J. Cobaleda, Eva Peñas‐Lledó, Adrián LLerena	2016	23
12	Polymorphic oxidation of debrisoquine in lung cancer patients European Journal of Cancer and Clinical Oncology ·Julio Benítez, JoséM. Ladero, Carlos Jara, Juan Antonio Carrillo, J. Cobaleda, Adrián LLerena, Emilio Vargas, Juan José Múñoz	1991	19
13	Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations Molecular Biology Reports ·Marisol López, Pedro Dorado, Alberto Ortega, Eva Peñas‐Lledó, Nancy Monroy‐Jaramillo, Irma Silva‐Zolezzi, J. Cobaleda, Alicia Gallego-Aguilera, María Elisa Alonso, Adrián LLerena	2012	17
14	Acetylator polymorphism in Parkinson's disease European Journal of Clinical Pharmacology ·José M. Ladero, Felipe Jiménez, J. Benítez, María J. Fernández-Gundín, Carmen Martínez, Adrián LLerena, J. Cobaleda, J. J. Mu�oz	1989	13
15	Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship Clinical Chemistry and Laboratory Medicine (CCLM) ·Pedro Dorado, Roland Berecz, Macarena C. Cáceres, Idilio González, J. Cobaleda, Adrián LLerena	2005	13
16	Polymorphic Oxidation of Debrisoquine in Bladder Cancer Annals of Medicine ·Julio Benítez, José M. Ladero, María J. Fernández-Gundín, Adrián LLerena, J. Cobaleda, Carmen Martı́nez, Juan José Múñoz, Emilio Vargas, Juan Prados, Fidel González-Rozas, Jesús Rodríguez-Molina, Aurelio C. Uson	1990	6
17	Debrisoquine Oxidation Phenotype in Psychiatric Patients PubMed ·J. Benítez, B. Piñas, Monserrat García, Carmen Martínez, Adrián LLerena, J. Cobaleda	1989	6
18	Clinical implementation of pharmacogenetics and personalized drug prescription based on e-health: the MedeA initiative Drug metabolism and drug interactions ·Adrián LLerena, Eva Peñas‐Lledó, Fernando de Andrés, Carmen Mata-Martín, Cristina Matesanz López, A. Pijierro-Amador, J. Cobaleda	2020	5
19	Debrisoquine oxidation in schizophrenic patients treated with neuroleptics Pharmacological Research Communications ·Edoardo Spina, Antoine Buemi, Achille P. Caputi, J. Benítez, J. Cobaleda, Monserrat García, Adrián LLerena, Benjamı́n Piña	1988	3
20	THE DEXTROMETHORPHAN PHENOTYPING TEST ACCURATELY PREDICTS DEBRISOQUIN HYDROXYLASE PHENOTYPE Anesthesiology ·M. J. Avram, T. K. Henthorn, T. C. Krejcie, J. Benítez, Robert D. Gibbons, Adrián LLerena, Carmen Martínez, J. Cobaleda	1988	2

About J. Cobaleda

J. Cobaleda is a scholar working on Pharmacology, Ophthalmology, Biological Psychiatry, Pharmacology and Oncology, having authored 20 papers that have together received 615 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Drug-Induced Ocular Toxicity (5 papers), Cancer Treatment and Pharmacology (4 papers), Pharmacological Effects and Toxicity Studies (2 papers), Cancer therapeutics and mechanisms (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Plant-based Medicinal Research (2 papers) and Traditional and Medicinal Uses of Annonaceae (1 paper). The work is most often cited by research in Pharmacology (376 citations), Biological Psychiatry (43 citations), Psychiatry and Mental health (111 citations), Biochemistry (46 citations) and Oncology (146 citations). J. Cobaleda has collaborated with scholars based in Spain, United States and Sweden. Frequent co-authors include Adrián LLerena, J. Benítez, Carmen Martínez, Julio Benítez, Gunnar Edman, Leif Bertilsson, Daisy Schalling, J. Benítez, Eva Peñas‐Lledó and Pedro Dorado. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The Pharmacogenomics Journal, European Journal of Clinical Pharmacology, Clinical Chemistry and Laboratory Medicine (CCLM) and Anesthesiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact